Drug Type Synthetic peptide, Diagnostic radiopharmaceuticals |
Synonyms (111)In-labeled αvβ6-specific (diethylenetriamine pentaacetate-tetra [DTPA]-A20FMDV2), 111In-DTPA-A20FMDV2 |
Target |
Mechanism αvβ6 modulators(Integrin alpha-V/beta-6 modulators), SPECT(Single-photon emission-computed tomography enhancers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Idiopathic Pulmonary Fibrosis | Preclinical | GB | 28 Oct 2013 |